Telomir Pharmaceuticals, Inc.
TELO • NASDAQ
Telomir Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Erez Aminov, with a market cap of $43.3M.
Market Cap$43.3M
CEOErez Aminov
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Telomir Pharmaceuticals, Inc. FAQ
Common questions about Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.